disease & medicine, cancer

The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.

Three-dimensional tissue cultures grown from cancer patients’ own tumors can predict responses to the drug irinotecan.

Three studies show that tumor cells can behave like neurons.

Recent federal announcements serve as reminders that in the US policy continues to outpace science when it comes to cannabis.

A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.

The Dana-Farber Cancer Institute researcher is developing cancer therapeutics based on how the physical structure of DNA contributes to the disease.

Curbing the growth of harmful bacteria in mouse microbiomes reduces the animals’ incidence of inflammation-related colorectal cancer.

The Johns Hopkins University researcher’s work helped solidify the link between human papillomavirus and cervical cancer, leading to the approval of the HPV vaccine in 2006.

An injectable biomaterial calls cancer drugs to tumor sites in mice.

Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.

Meet some of the people featured in the July/August 2019 issue of The Scientist.

Meet researcher Elaine Mardis of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Ohio and coauthor of a feature article on cancer vaccines.

The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.

Selected Images of the Day from the-scientist.com

The Purdue University nutrition researcher delves into the details of how fat tissue affects tumors.

Comparing the cells of cancer patients who did and did not respond to the immunotherapy could reveal biomarkers to predict who should receive it in the first place.

See how a computational pipeline uses next-generation sequencing data to identify genetic alterations that produce cancer-specific antigens.

The field is young, but predicting antigens produced by patients’ malignant cells could yield successful treatments for individuals with a range of cancer types.

Research in mice and humans is beginning to establish a link between the composition of microbes in the gut and immune responses to tumor cells, but the mechanisms are not yet clear.